Circular RNAs in pancreatic cancer progression

Haolin Bao; Jiehan Li; Qingfu Dong; Zixin Liang; Chengru Yang; Yi Xu

doi:10.1016/j.cca.2023.117633

Circular RNAs in pancreatic cancer progression

Clin Chim Acta. 2024 Jan 1:552:117633. doi: 10.1016/j.cca.2023.117633. Epub 2023 Nov 8.

Authors

Haolin Bao¹, Jiehan Li¹, Qingfu Dong¹, Zixin Liang¹, Chengru Yang¹, Yi Xu²

Affiliations

¹ Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China.
² Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, China; Department of Pathology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong 999077, China; Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, Guizhou 563006, China; Key Laboratory of Functional and Clinical Translational Medicine, Fujian Province University, Xiamen Medical College, Xiamen, Fujian 361000, China; Anhui Province Key Laboratory of Translational Cancer Research, Bengbu Medical College, Bengbu, Anhui 233030, China; Jiangsu Province Engineering Research Center of Tumor Targeted Nano Diagnostic and Therapeutic Materials, Yancheng Teachers University, Yancheng, Jiangsu 224007, China; Key Laboratory of Biomarkers and In Vitro Diagnosis Translation of Zhejiang Province, Hangzhou, Zhejiang 310000, China; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350122, China; State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, Guangdong 518055, China; Key Laboratory of Intelligent Pharmacy and Individualized Therapy of Huzhou and Department of Pharmacy, Changxing People's Hospital, Changxing, Zhejiang 313000, China. Electronic address: xuyihrb@pathology.hku.hk.

PMID: 37949391
DOI: 10.1016/j.cca.2023.117633

Abstract

Pancreatic cancer (PC), typically diagnosed at relatively advanced stages with poor prognosis, is a dominant cause of cancer-related deaths worldwide. Accumulating evidence demonstrates that circular RNAs (circRNAs) are abnormally expressed in diverse tumors and affect tumorigenesis and progression. In this article, we examine the roles of circRNAs in regulation of PC progression. Additionally, circRNAs enriched in exosomes could be transferred among PC cells to modulate malignancy. Characterization of regulatory mechanisms involving circRNAs in general and PC specifically will enable earlier detection and potential development of therapeutic strategies.

Keywords: Biomarker; Cancer therapy; Chemoresistance; CircRNA; Exosome; Pancreatic cancer.

Publication types

Review

MeSH terms

Humans
Pancreatic Neoplasms* / genetics
RNA / genetics
RNA, Circular* / genetics
RNA, Messenger

Substances

RNA, Circular
RNA
RNA, Messenger